A recent study proposes a preliminary symptom-based rule that can be used to identify cases of postacute sequelae of SARS-CoV-2 infection (PASC), also known as long COVID. The study was led by Instructor in the Department of Biostatistics, HSPH and Associate Director, Biostatistics Research and Engagement for MGH Biostatistics, Dr. Tanayott Thaweethai, and Professor in the Department of Biostatistics, HSPH and Director of Biostatistics at Massachusetts General Hospital, Dr. Andrea S. Foulkes, (both are also currently faculty at Harvard Medical School). The paper, published online by JAMA, leverages data collected and analyzed from 9764 participants in the RECOVER adult cohort, a prospective longitudinal cohort study and identifies 12 major symptoms. The study has received wide media coverage and is a significant launching point for future research into understanding risk factors, mechanisms of disease, and potential therapies for long COVID. For more on the study and its impact, see coverage by coverage in the Washington Post, the LA Times, CNN, PBS, Mass General Brigham and the NIH.
Biostats Faculty Publish Study Helping Define Long COVID
